Evidence map›Paper›PMID 31408961›Full record

ArticleInternational journal of environmental research and public health2019

Long-Term Trends of Liver Cancer Incidence and Mortality in China 1990-2017: A Joinpoint and Age-Period-Cohort Analysis.

Fang Wang, Sumaira Mubarik, Yu Zhang, Lu Wang, Yafeng Wang, Chuanhua Yu, Hao Li

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. [Predictive role of dynamic changes in liver stiffness measurement for liver-related endpoint events in chronic hepatitis B].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. The mortality of oral cancer attributable to tobacco in China, the US, and India.Journal of cancer research and clinical oncology · 2023
    Article
  15. Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022).Journal of clinical and translational hepatology · 2023
    Article
  16. Article
  17. Cancer morbidity and mortality trends in Trinidad and Tobago (2008-2018).Journal of health, population, and nutrition · 2023
    Article
  18. [Interpretation of the essential updates in guidelines for the prevention and treatment of chronic hepatitis B (Version 2022)].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fang WangDepartment of Epidemiology and Biostatistics, School of Health Sciences, Wuhan University, Wuhan 430071, China.
Sumaira MubarikDepartment of Epidemiology and Biostatistics, School of Health Sciences, Wuhan University, Wuhan 430071, China.ORCID 0000-0001-6041-1061
Yu ZhangSchool of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Lu WangMedical College of Hubei University of Arts and Science, Xiangyang 441053, China.
Yafeng WangDepartment of Epidemiology and Biostatistics, School of Health Sciences, Wuhan University, Wuhan 430071, China.
Chuanhua YuDepartment of Epidemiology and Biostatistics, School of Health Sciences, Wuhan University, Wuhan 430071, China. YuCHua@whu.edu.cn.ORCID 0000-0002-5467-2481
Hao LiDepartment of Epidemiology and Biostatistics, School of Health Sciences, Wuhan University, Wuhan 430071, China. h.li@whu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver cancer (LC) is one of the most common causes of cancer-related deaths: this study aims to present the long-term trends and age-period-cohort effects of the incidence of and mortality from LC in China during 1990-2017. Incidence and mortality data were obtained from the Global Burden of Disease Study 2017. We determined trends in the age-standardized incidence rate (ASIR) and mortality rate (ASMR) using Joinpoint regression. An age-period-cohort (APC) analysis was performed to describe the long-term trends with intrinsic estimator methods. The ASMR decreased markedly before 2013 and increased thereafter, with overall average annual percent change (AAPC) values of -0.5% (95% confidence interval (CI): -0.6%, -0.3%) for men and -1.3% (-1.6%, -1.0%) for women during 1990-2017. The ASIR significantly increased by 0.2% (0.1%, 0.3%) in men and decreased by 1.1% (-1.2%, -1.0%) in women from 1990 to 2017. The risks of LC incidence and mortality increased with age in both genders. The period effect risk ratios (RRs) of incidence and mortality displayed similar monotonic increasing trends in men and remained stable in women. The cohort effect showed an overall downward trend and almost overlapping incidence and mortality in both genders, and later birth cohorts experienced lower RRs than previous birth cohorts. Older age, recent period, and birth before 1923 were associated with a higher risk of liver cancer incidence and mortality. The net age and period effects showed an increasing trend, while the cohort effects presented a decreasing trend in incidence and mortality risk. As China's population aging worsens and with the popularization of unhealthy lifestyles, the burden caused by liver cancer will remain a huge challenge in China's future.

Indexed as

AdultAgedAged, 80 and overChinaCohort EffectCohort StudiesFemaleHumansIncidenceLife StyleLiver NeoplasmsMaleMiddle AgedOdds RatioYoung Adultage–period–cohort modelincidenceJoinpoint regression analysisliver cancermortalitytrends

Identifiers

PMID31408961
PMCPMC6719938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.